Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Epigral has scheduled its 19th Annual General Meeting (AGM) for June 8, 2026, via Video Conference. The board recommended a dividend of Rs.5.00 per equity share for FY26, and the record date for this dividend is fixed as June 1, 2026.
May 18 2026 18:05:00
Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Epigral will participate in the Centrum's Nakshatra III Conference. The virtual event is scheduled for May 20, 2026, providing an opportunity to interact with investors and analysts.
May 18 2026 18:05:00
Epigral Limited
Epigral Limited's Board recommended a dividend of Rs.5 per equity share for the financial year 2025-26. The record date for determining eligible shareholders is June 01, 2026. This dividend is subject to shareholder approval at the upcoming 19th Annual General Meeting.
May 18 2026 18:05:00
Epigral Ltd - 543332 - Business Responsibility and Sustainability Reporting (BRSR)
Epigral has significantly advanced its ESG initiatives for FY26, including the establishment of an 18.34 MW wind-solar hybrid project and efforts to achieve carbon neutrality by 2030, targeting 50% renewable energy use by 2028.
May 15 2026 18:05:00
Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Epigral is scheduled to hold a one-on-one meeting with Systematix Group on May 8, 2026, via video conferencing. The company confirmed that no unpublished price sensitive information will be discussed.
May 06 2026 18:05:00
Epigral Limited
Epigral Ltd submitted the transcript of its Q4 FY26 earnings conference call. The call discussed the company's record Q4 revenue of Rs.736 crore, strong EBITDA and PAT growth, and an optimistic outlook for FY27 volume growth and ongoing capex projects.
May 06 2026 13:05:00
Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Epigral announced the availability of the audio recording for its conference call held on May 2, 2026. This call discussed the Q4 FY2026 financial results, providing investors access to detailed discussions.
May 03 2026 20:05:00
Epigral Limited
Epigral Limited's Board has recommended a final dividend of Rs. 5 per equity share for the financial year 2025-26. The record date and book closure details will be announced in due course.
May 02 2026 16:05:00
Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Epigral reported a record revenue of Rs 736 crore for Q4 FY26, marking a 17% YoY growth. Net profit for the quarter rose 109% sequentially to Rs 82 crore. The company also proposed a final dividend of Rs 5 per equity share for FY2026 and spent Rs 394 crore on capex in FY2026.
May 02 2026 16:05:00
Epigral Ltd - 543332 - Board Meeting Outcome for Approved Audited Financial Results (Standalone & Consolidated) For The Fourth Quarter And
Year Ended On 31St March, 2026 And Recommended Final Dividend Of Rs. 5.00 (50%) Per Equity Share
Epigral's board approved Q4 FY26 cons. financial results, with revenue at ₹736.16 crore and net profit at ₹80.95 crore. The company also recommended a final dividend of ₹5.00 per equity share for FY26, to be paid as per the provisions of the Companies Act.
May 02 2026 15:05:00
Read More